These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 9402786)
21. Involuntary weight loss in patients with advanced cancer: treatment is of modest benefit. J Support Oncol; 2006 Feb; 4(2):92. PubMed ID: 16499134 [No Abstract] [Full Text] [Related]
22. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002. Hannibal CG; Cortes R; Engholm G; Kjaer SK Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210 [TBL] [Abstract][Full Text] [Related]
23. Travel times to health care and survival from cancers in Northern England. Jones AP; Haynes R; Sauerzapf V; Crawford SM; Zhao H; Forman D Eur J Cancer; 2008 Jan; 44(2):269-74. PubMed ID: 17888651 [TBL] [Abstract][Full Text] [Related]
24. Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer. Martin JH; Coory MD; Valery PC; Green AC Cancer Causes Control; 2009 Apr; 20(3):355-60. PubMed ID: 18953694 [TBL] [Abstract][Full Text] [Related]
25. How to interpret the relative survival ratios of cancer patients. Pokhrel A; Hakulinen T Eur J Cancer; 2008 Nov; 44(17):2661-7. PubMed ID: 18819791 [TBL] [Abstract][Full Text] [Related]
26. Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed. Brenner H; Arndt V Eur J Cancer; 2005 Feb; 41(3):438-44. PubMed ID: 15691645 [TBL] [Abstract][Full Text] [Related]
27. A Greenwood formula for standard error of the age-standardised relative survival ratio. Pokhrel A; Dyba T; Hakulinen T Eur J Cancer; 2008 Feb; 44(3):441-7. PubMed ID: 18053707 [TBL] [Abstract][Full Text] [Related]
28. Computer-assisted predictive formulas expressing survival probability and life expectancy in US adults, men and women, 2001. Chung SJ Comput Methods Programs Biomed; 2007 Jun; 86(3):197-209. PubMed ID: 17459517 [TBL] [Abstract][Full Text] [Related]
29. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group. Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J; J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610 [TBL] [Abstract][Full Text] [Related]
30. Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis. Ritoe SC; de Vegt F; Scheike IM; Krabbe PF; Kaanders JH; van den Hoogen FJ; Verbeek AL; Marres HA Cancer; 2007 Jan; 109(2):239-47. PubMed ID: 17154185 [TBL] [Abstract][Full Text] [Related]
31. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Viganò A; Dorgan M; Bruera E; Suarez-Almazor ME Cancer; 1999 Jul; 86(1):170-6. PubMed ID: 10391577 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of influenza vaccination in working-age cancer patients. Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827 [TBL] [Abstract][Full Text] [Related]
33. Are patients diagnosed with breast cancer before age 50 years ever cured? Brenner H; Hakulinen T J Clin Oncol; 2004 Feb; 22(3):432-8. PubMed ID: 14691121 [TBL] [Abstract][Full Text] [Related]
34. The GAME estimate of reduced life expectancy. van den Hout WB Med Decis Making; 2004; 24(1):80-8. PubMed ID: 15005957 [TBL] [Abstract][Full Text] [Related]
35. Fraction of normal remaining life span: a new method for expressing survival in cancer. Vaidya JS; Mittra I BMJ; 1997 Jun; 314(7095):1682-4. PubMed ID: 9193295 [No Abstract] [Full Text] [Related]
36. New method of expressing survival in cancer is popular. Vaidya JS; Mittra I BMJ; 1998 Apr; 316(7137):1092. PubMed ID: 9552922 [No Abstract] [Full Text] [Related]
37. [Principles of calculation of survival time in malignant neoplasms]. Pawlega J; Kołodziejska H Nowotwory; 1981; 30(4):337-45. PubMed ID: 7279688 [No Abstract] [Full Text] [Related]
38. Cancer survival is no lottery. Ozonoff D; Clapp R Lancet; 1999 Apr; 353(9162):1379-80. PubMed ID: 10227215 [No Abstract] [Full Text] [Related]
39. Giving is the Key to Survival. Harari VE Pract Radiat Oncol; 2019 Nov; 9(6):e484. PubMed ID: 31002884 [No Abstract] [Full Text] [Related]
40. Difference in Restricted Mean Survival Times as a Measure of Effect Size: No Assumption Does Not Mean No Rule. de Boissieu P; Chevret S J Clin Oncol; 2024 Aug; 42(24):2942-2943. PubMed ID: 38913965 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]